ELI LILLY AND COMPANY

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology MATTERS Rank in Class
 
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 456 32
 
 
C07D HETEROCYCLIC COMPOUNDS 307 20
 
 
C07K PEPTIDES 106 45
 
 
A61M DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY 66 88
 
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 46 50
 
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 41 97
 
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 37 130
 
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 33 66
 
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 29 70
 
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 23 27
  • No Technologies to Display

Top Patents (by citation)

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0064,882 DISPENSING DEVICE WITH DRIVE MECHANISM HAVING CONVERGING RAMPS Mar 10, 16 Mar 08, 18 [A61M]
2018/0016,318 Novel Fatty Acid Modified Urocortin-2 Analogs for the Treatment of Diabetes and Chronic Kidney Disease Jul 13, 17 Jan 18, 18 [A61K, C07K]
2018/0009,908 IgG Bispecific Antibodies and Processes for Preparation Jan 21, 16 Jan 11, 18 [C07K]
2018/0000,904 NASAL POWDER FORMULATION FOR TREATMENT OF HYPOGLYCEMIA Feb 16, 16 Jan 04, 18 [A61M, A61K]
2017/0326,128 Novel Methyl-Piperidine Compounds Useful for Inhibiting Microsomal Prostaglandin E2 Synthase-1 Oct 22, 15 Nov 16, 17 [C07D, A61K]
2017/0313,679 Novel Carboxylic Acid Compounds Useful for Inhibiting Microsomal Prostaglandin E2 Synthase-1 Oct 22, 15 Nov 02, 17 [C07D, C07C]
2017/0283,394 NOVEL INTERMEDIATE AND PROCESS USEFUL IN THE PREPARATION OF -(2-CHLOROPHENYL)-METHANONE Jun 15, 17 Oct 05, 17 [C07D]
2017/0259,008 RIGID NEEDLE SHIELD GRIPPING CAP ASSEMBLY Feb 06, 15 Sep 14, 17 [A61M]
2017/0246,166 1,2-BENZOTHIAZOLE COMPOUNDS FOR THE TREATMENT OF KIDNEY DISORDERS Nov 13, 15 Aug 31, 17 [C07D, A61K]
2017/0246,399 SENSING SYSTEM FOR DETECTING A PISTON IN A MEDICAL FLUID CONTAINER Aug 27, 15 Aug 31, 17 [A61M]

View all publication…

  • No Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9920056 2-oxo-1,3,8-triazaspiro[4.5]decan-3-yl] carboxylic acid derivatives Jun 08, 16 Mar 20, 18 [C07D]
9913943 Trigger assembly for an automatic injection device Mar 07, 14 Mar 13, 18 [A61M]
9901623 Rapid-acting insulin compositions Aug 19, 16 Feb 27, 18 [A61K]
9884093 Glucagon receptor agonists Oct 14, 16 Feb 06, 18 [A61K, C07K]
9879029 ERK inhibitors Dec 15, 15 Jan 30, 18 [C07D, C07B]
9872853 2,3-dihydro-1H-indole compounds May 31, 17 Jan 23, 18 [C07D, C07C, A61K]
9872961 Automatic injection device with trigger assembly Oct 11, 13 Jan 23, 18 [A61M]
9868741 PDE1 inhibitor Feb 03, 17 Jan 16, 18 [C07D]
9861613 GPR142 agonist compounds Jan 22, 15 Jan 09, 18 [A61K]
9861750 Process and device for delivery of fluid by chemical reaction Apr 06, 16 Jan 09, 18 [A61M, B65D]

View all Patent…

  • No Patents to Display

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2016/0361,390 GLP-1 RECEPTOR AGONIST COMPOUNDS FOR OBSTRUCTIVE SLEEP APNEA ABAN Aug 26, 16 Dec 15, 16 [A61K]
2016/0229,835 NOVEL PYRIDYLOXYACETYL TETRAHYDROISOQUINOLINE COMPOUNDS USEFUL AS NAMPT INHIBITORS ABAN Oct 03, 14 Aug 11, 16 [C07D, A61K]
2015/0376,178 Pyridinoylpiperidines As 5-HT1F Agonists ABAN Jun 05, 14 Dec 31, 15 [C07D]
2015/0322,083 (THIENO[2,3-b][1,5]BENZOXAZEPIN-4-YL)PIPERAZIN-1-YL COMPOUNDS AS SELECTIVE 5-HT2A INVERSE AGONISTS ABAN Apr 22, 15 Nov 12, 15 [C07D]
2015/0258,177 GLP-1 RECEPTOR AGONIST COMPOUNDS FOR OBSTRUCTIVE SLEEP APNEA ABAN Jun 02, 15 Sep 17, 15 [A61K]
2015/0203,471 METHODS FOR IMPROVING CHICKEN PRODUCTION ABAN Sep 24, 13 Jul 23, 15 [C07D, C07C, A23K]
2015/0183,877 Multi-Specific IgG-(Fab)2 Constructs Containing T-Cell Receptor Constant Domains ABAN Jul 15, 13 Jul 02, 15 [C07K]
2015/0152,158 METHODS TO RESTORE GLYCEMIC CONTROL ABAN Feb 10, 15 Jun 04, 15 [C07K]
2015/0141,335 THERAPEUTIC USES OF FIBROBLAST GROWTH FACTOR 21 PROTEINS ABAN May 09, 13 May 21, 15 [A61K]
2015/0045,313 Ectoparasiticidal Methods and Formulations ABAN Oct 28, 14 Feb 12, 15 [A01N]
2014/0271,671 RANDOM HOMOZYGOUS GENE PERTURBATION (RHGP) WITH THERMAL ASSYMETRIC INTERLACED (TAIL)-PCR ABAN Mar 14, 13 Sep 18, 14 [C12Q]
2014/0275,049 SUBSTITUTED PYRAZOLE ANALOGS As RAR ANTAGONISTS ABAN Oct 19, 12 Sep 18, 14 [C07D, A61K]
2014/0206,613 METHODS TO RESTORE GLYCEMIC CONTROL ABAN Mar 31, 14 Jul 24, 14 [C07K]
2014/0206,877 NOVEL INTERMEDIATE AND PROCESS USEFUL IN THE PREPARATION OF -(2-CHLOROPHENYL)-METHANONE ABAN Mar 27, 14 Jul 24, 14 [C07D]
2014/0171,497 ANIMAL SUPPLEMENTS AND COMPOSITIONS CONTAINING SOLUABLE MONENSIN AND METHODS THEREFOR ABAN Jul 26, 12 Jun 19, 14 [A23K, A61K]
2014/0163,097 ANIMAL SUPPLEMENTS AND FOOD COMPOSITIONS CONTAINING SOLUBLE MONENSIN COMPOSITION, AND METHODS AND PROCESSES THEREFOR ABAN Jul 26, 12 Jun 12, 14 [A23K, A61K]
2014/0056,893 Homodimeric Proteins ABAN Aug 15, 13 Feb 27, 14 [C07K]
2014/0050,763 MODIFIED VIRAL PARTICLES WITH IMMUNOGENIC PROPERTIES AND REDUCED LIPID CONTENT USEFUL FOR TREATING AND PREVENTING INFECTIOUS DISEASES ABAN Oct 30, 13 Feb 20, 14 [A61K]
2014/0024,586 USE OF AN FGF-21 COMPOUND AND A GLP-1 COMPOUND FOR THE TREATMENT OF OBESITY ABAN Oct 03, 13 Jan 23, 14 [A61K]
2013/0228,136 LIQUID DISPENSER ABAN Apr 17, 13 Sep 05, 13 [A01K]

View all Patent…

  • No Patents to Display

Top Inventors for This Owner

We are sorry but your current selection exceeds the maximum number of watches () for this membership level. Upgrade to our Level for up to watches!

Owner Watch
ELI LILLY AND COMPANY
CANCEL
UPGRADE MEMBERSHIP CANCEL

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to comparisons!

UPGRADE MEMBERSHIP CANCEL

We are sorry but your current selection exceeds the maximum number of portfolios () for this membership level. Upgrade to our Level for up to portfolios!

UPGRADE MEMBERSHIP CANCEL

We are sorry but your current selection exceeds the maximum number of patents allowed in portfolios () for this membership level. Upgrade to our Level for up to patents!

UPGRADE MEMBERSHIP CANCEL